Skip to Main Content
An official website of the United States government
CDAS has a New Look: On December 9th, the CDAS website was updated with a new design! The update incorporates all of the existing CDAS functionality with a more modern and user friendly interface.

Use of GWAS data to address the association between Human Leukocyte Antigen (HLA) and cancer

Principal Investigator

Name
Zhiwei Liu

Degrees
Ph.D.

Institution
National Cancer Institute

Position Title
Investigator

Email
zhiwei.liu@nih.gov

About this CDAS Project

Study
PLCO (Learn more about this study)

Project ID
PLCO-375

Initial CDAS Request Approval
Jun 22, 2018

Title
Use of GWAS data to address the association between Human Leukocyte Antigen (HLA) and cancer

Summary
Human leukocyte antigen (HLA) region resides on chromosome 6 and contains a large number of genes related to immune system function. It plays a central role in presentation of antigens to the immune system, and is characterized by high polymorphism at the gene and haplotype level and strong linkage disequilibrium patterns. HLA genes are classified by Class I, Class II, and non-Class I/II genes according to different immune function. Previous studies show that HLA genes are associated with cancer risk. Based on a previously approved project using Total Genome Set (TGS), we analyzed genotypes for all SNPs in a region 20KB wider than the MHC region (chr6: 28437797 to 33488354 in b37/hg19). PLCO project is one of the participating studies. We thus request information on phenotypes and covariates, including case-control status, histological types of cases, age (continuous), sex and race/ethnicity.

Aims

1) Which cancers have/do not have genetic associations within the MHC region
2) Do cancers associated with EBV infection have stronger evidence for genetic associations within the HLA Class I region, other infection-associated cancers and hematopoetic cancers have stronger evidence for associations within the HLA Class II regions, and other solid tumors with no know infectious cause either have no evidence of associations in the MHC region or have stronger evidence for associations within the non-HLA Class I/II regions of the MHC.

Collaborators

Ruth Pfeiffer, NCI/DCEG
Andriy Derkach, NCI/DCEG
Kelly Yu, NCI/DCEG
Zhiwei Liu, NCI/DCEG

Related Publications